top of page

NEXT-GEN

DIGITAL THERAPEUTICS

A billion quality of life years for humanity

CUTTING EDGE

DIGITAL THERAPEUTICS

Welcome to HTx, the leading digital therapeutics company. We provide cutting-edge treatments to improve the health and quality of life of individuals around the world. Our evidence-based approach combines the latest in digital technology with clinically-validated therapeutic interventions. 

01
One Click

Digital Biomarkers

02
One Click

Therapeutic 

Agent

03
Platform for Digital Therapeutics

04
Democratizing and Decentralizing

DRIVEN BY PERFORMANCE

HTx is a digital therapeutics company that is providing a digital biomarker based platform to democratize and decentralize access to advanced technology in the biotech space, driven by performance. By leveraging data-driven analytics, HTx can provide data-driven insights to identify potential treatments and therapies that may be more effective for certain patient populations.

 

By utilizing HTx’s platform, direct access to advanced technologies in the biotech space is available to individuals and organizations of all sizes, allowing them to take advantage of high-performance solutions without the need for expensive software or hardware. Ultimately, HTx is providing a unique way to bring advanced technology to the healthcare space, allowing for better patient care.

380K+

Data points

25+

Biomarkers

15+

Medical partners

95%

Accuracy

HTx OFFICES

With offices spanning the globe, HTx's headquarters is located in Boston, MA, with a branch, named HAII, in Seoul, South Korea.

In addition, HTx is in the process of opening two new offices in Bombay, India and Dubai, UAE, allowing them to better serve a global audience. By expanding their presence into these countries, HTx will be able to create even more innovative and effective digital therapeutics solutions for a wide range of medical conditions.

BOSTON

USA

contact@haii.io

1 Broadway St

Cambridge, MA 

SEOUL

KOREA

+82 2-313-1236

contact@haii.io

HAII Korea

Seoul, KR

WE HAVE PARTNERS  WITH LEADING EXPERTISE AND EXPERIENCE

FEATURED RESEARCH

AND DATA OF HTx

Clinical Validation Studies on the 

Assessment Accuracy of Alzguard-D and Treatment Efficacy of Alzguard-T

Jee Hang Lee, Professor at Sangmyung University

A Preliminary Feasibility Study on Screening Cognitive Impairment based on Multi-Modal Biomarkers and Stacking Ensemble AI Approach

HAII Korea

Can Software Robot Enhance Cognitive Capacity of Senior People?: a Longitudinal Exploratory Field Study with Korean Elderlies

HAII Korea

SYNC OUR SOLUTIONS WITH YOUR NEEDS

See how our tailored software solutions fit your business too.

bottom of page